Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Bryant

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Cytotherapy|September 3, 2022
Incomplete chimerism following myeloablative and anti-thymocyte globulin-conditioned hematopoietic cell transplantation is a risk factor for relapse and chronic graft-versus-host diseaseRutvij A Khanolkar, Gaurav Tripathi, Poonam Dharmani-Khan, et al.
Cytokine|January 12, 2010
IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markersSarah C Sasson, Sandy Smith, Nabila Seddiki, et al.
Developmental Cognitive Neuroscience|February 15, 2024
Brain network connectivity during peer evaluation in adolescent females: Associations with age, pubertal hormones, timing, and statusAndrea Pelletier-Baldelli, Margaret A Sheridan, Marc D Rudolph, et al.
European Journal of Haematology|July 3, 2024
A single-day polychemotherapy regimen with proteasome inhibitor combinations for relapsed/refractory myeloma in the era of novel therapiesEric Wenlong Li, Esther Jones, Christian Bryant, et al.
Clinical Hematology International|January 19, 2023
Phase I Study of Safety and Pharmacokinetics of RO7297089, an Anti-BCMA/CD16a Bispecific Antibody, in Patients with Relapsed, Refractory Multiple MyelomaTorben Plesner, Simon J Harrison, Hang Quach, et al.
Biological Psychiatry|November 2, 2023
Neural Markers of Emotion Reactivity and Regulation Before and After a Targeted Social Rejection: Differences Among Girls With and Without Suicidal Ideation and Behavior HistoriesAdam Bryant Miller, Jessica L Jenness, Amanda L Elton, et al.
Internal Medicine Journal|May 30, 2026
Australian clinical practice guideline: diagnosis and treatment of idiopathic multicentric Castleman diseaseDipti Talaulikar, Jun Yen Ng, Adam Bryant, et al.
Asia-Pacific Journal of Clinical Oncology|March 23, 2026
Efficacy and Tolerability of Weekly Bortezomib, Lenalidomide, and Dexamethasone Protocols in Transplant-Ineligible Newly Diagnosed Myeloma: An Australian Real-World, Multicenter StudySamantha Kurniawan, Angela Hwang, Nicole Wong Doo, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|April 16, 2023
Neural Correlates of the p Factor in Adolescence: Cognitive Control With and Without Enhanced Positive Affective DemandsAnaïs M Rodriguez-Thompson, Adam Bryant Miller, Mark Wade, et al.
The American Psychologist|March 13, 2023
Culturally responsive assessment of suicidal thoughts and behaviors in youth of colorSherry D Molock, Rhonda C Boyd, Kiara Alvarez, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Cytotherapy|September 3, 2022
Incomplete chimerism following myeloablative and anti-thymocyte globulin-conditioned hematopoietic cell transplantation is a risk factor for relapse and chronic graft-versus-host diseaseRutvij A Khanolkar, Gaurav Tripathi, Poonam Dharmani-Khan, et al.
Cytokine|January 12, 2010
IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markersSarah C Sasson, Sandy Smith, Nabila Seddiki, et al.
Developmental Cognitive Neuroscience|February 15, 2024
Brain network connectivity during peer evaluation in adolescent females: Associations with age, pubertal hormones, timing, and statusAndrea Pelletier-Baldelli, Margaret A Sheridan, Marc D Rudolph, et al.
European Journal of Haematology|July 3, 2024
A single-day polychemotherapy regimen with proteasome inhibitor combinations for relapsed/refractory myeloma in the era of novel therapiesEric Wenlong Li, Esther Jones, Christian Bryant, et al.
Clinical Hematology International|January 19, 2023
Phase I Study of Safety and Pharmacokinetics of RO7297089, an Anti-BCMA/CD16a Bispecific Antibody, in Patients with Relapsed, Refractory Multiple MyelomaTorben Plesner, Simon J Harrison, Hang Quach, et al.
Biological Psychiatry|November 2, 2023
Neural Markers of Emotion Reactivity and Regulation Before and After a Targeted Social Rejection: Differences Among Girls With and Without Suicidal Ideation and Behavior HistoriesAdam Bryant Miller, Jessica L Jenness, Amanda L Elton, et al.
Internal Medicine Journal|May 30, 2026
Australian clinical practice guideline: diagnosis and treatment of idiopathic multicentric Castleman diseaseDipti Talaulikar, Jun Yen Ng, Adam Bryant, et al.
Asia-Pacific Journal of Clinical Oncology|March 23, 2026
Efficacy and Tolerability of Weekly Bortezomib, Lenalidomide, and Dexamethasone Protocols in Transplant-Ineligible Newly Diagnosed Myeloma: An Australian Real-World, Multicenter StudySamantha Kurniawan, Angela Hwang, Nicole Wong Doo, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|April 16, 2023
Neural Correlates of the p Factor in Adolescence: Cognitive Control With and Without Enhanced Positive Affective DemandsAnaïs M Rodriguez-Thompson, Adam Bryant Miller, Mark Wade, et al.
The American Psychologist|March 13, 2023
Culturally responsive assessment of suicidal thoughts and behaviors in youth of colorSherry D Molock, Rhonda C Boyd, Kiara Alvarez, et al.
Pageof 12